Extreme short bowel syndrome: a case for reviewing the guidelines for predicting survival.
IV Divisione Lattanti, Ospedale G. Di Cristina, Palermo, Italy.
G
G
Iacono
A
A
Carroccio
G
G
Montalto
F
F
Cavataio
M
M
Lo Cascio
A
A
Notarbatolo
D000138:Acidosis / Q000188:drug therapy / Q000209:etiology; D001424:Bacterial Infections / Q000188:drug therapy / Q000209:etiology; D001639:Bicarbonates / Q000627:therapeutic use; D001942:Breast Feeding; D002408:Catheters, Indwelling / Q000009:adverse effects; D003968:Diarrhea, Infantile / Q000188:drug therapy / Q000209:etiology; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D007415:Intestinal Obstruction / Q000601:surgery; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D008895:Milk, Human; D009355:Neomycin / Q000627:therapeutic use; D010288:Parenteral Nutrition; D011899:Ranitidine / Q000627:therapeutic use; D012778:Short Bowel Syndrome / Q000150:complications / Q000628:therapy*; D012964:Sodium / Q000627:therapeutic use; D017693:Sodium Bicarbonate; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D014839:Vomiting
D001639:Bicarbonates; D008795:Metronidazole; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D011899:Ranitidine; D017693:Sodium Bicarbonate; D012964:Sodium; D009355:Neomycin